ctrl K

Watchlist Price Alert

Bioventus Inc. (BVS)

NASDAQ: BVS · Real-Time Price · USD

6.78

0.24 (3.67%)

At close: May 16, 2025, 3:59 PM

6.75

-0.44%

After-hours: May 16, 2025, 04:10 PM EDT

Bioventus Revenue Breakdown

Period Ending	Dec 31, 2024
International Segment Revenue	66.47M
International Segment Revenue Growth	n/a
U.S. Segment Revenue	506.81M
U.S. Segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 29, 2025	Dec 31, 2024	Sep 28, 2024	Jun 29, 2024	Mar 30, 2024	Dec 31, 2023	Sep 30, 2023	Jul 1, 2023	Apr 1, 2023	Dec 31, 2022	Oct 1, 2022	Jul 2, 2022	Apr 2, 2022	Dec 31, 2021	Oct 2, 2021	Jul 3, 2021	Apr 3, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 28, 2019	Jun 29, 2019	Mar 29, 2019	Mar 31, 2016	Mar 31, 2015
Selling, General, and Administrative Revenue	73.5M	86.61M	81.09M	94.78M	78.41M	78.36M	69.82M	74.84M	80.86M	77.44M	78.95M	89.62M	86.12M	80.88M	69.64M	69.05M	34.69M	61.97M	50.3M	40.53M	40.28M	54.45M	45.12M	49.45M	49.45M	40.18M	37.27M
Selling, General, and Administrative Revenue Growth	-15.14%	+6.81%	-14.45%	+20.89%	+0.06%	+12.23%	-6.71%	-7.44%	+4.42%	-1.93%	-11.90%	+4.06%	+6.48%	+16.15%	+0.85%	+99.07%	-44.03%	+23.22%	+24.08%	+0.64%	-26.04%	+20.69%	-8.76%	0.00%	+23.06%	+7.82%	n/a
Research and Development Revenue	3.01M	3.25M	3.81M	3.99M	2.6M	3.26M	3.02M	3.4M	3.77M	6.81M	4.61M	6.37M	6.93M	7.1M	6.15M	4.84M	947K	2.89M	3.57M	2.6M	2.15M	3.14M	2.85M	2.53M	2.53M	3.72M	2.97M
Research and Development Revenue Growth	-7.24%	-14.76%	-4.51%	+53.56%	-20.39%	+8.19%	-11.27%	-9.89%	-44.60%	+47.53%	-27.52%	-8.11%	-2.46%	+15.44%	+27.23%	+410.67%	-67.24%	-19.00%	+37.48%	+20.97%	-31.74%	+10.51%	+12.41%	0.00%	-31.93%	+25.35%	n/a